Bg pattern

AMBROXOL STADA 6 mg/ml SYRUP

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use AMBROXOL STADA 6 mg/ml SYRUP

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show translation

Introducción

Prospecto: información para el paciente

Ambroxol Stada 6 mg/ml jarabe EFG

Lea todo el prospecto detenidamente antes de empezar a tomar este medicamento, porque contiene información importante para usted.

  • Conserve este prospecto, ya que puede tener que volver a leerlo.
  • Si tiene alguna duda, consulte a su médico o farmacéutico.
  • Este medicamento se le ha recetado solamente a usted, y no debe dárselo a otroas personas aunque tengan los mismos síntomas que usted, ya que puede perjudicarles.
  • Si experimenta efectos adversos, consulte a su médico o farmacéutico, incluso si se trata de efectos adversos que no aparecen en este prospecto. Ver sección 4.

Contenido del prospecto

  1. Qué es Ambroxol Stada y para qué se utiliza
  2. Qué necesita saber antes de empezar a tomar usar Ambroxol Stada
  3. Cómo tomar Ambroxol Stada
  4. Posibles efectos adversos
  5. Conservación de Ambroxol Stada
  6. Contenido del envase e información adicional

1. Qué es Ambroxol Stada y para qué se utiliza

Ambroxol Stada contiene el principio activo ambroxol hidrocloruro que pertenece al grupo de medicamentos llamados mucolíticos. Se utiliza para facilitar la eliminación de los mocos de las vías respiratorias en afecciones con moco espeso (expectorante).

Ambroxol Stada está indicado para el tratamiendo de disolución de moco en afecciones de los bronquios y pulmones con moco espeso para adultos, adolescentes y niños a partir de 2 años.

Debe consultar a un médico si empeora o si no mejora después de 4-5 días.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. Qué necesita saber antes de empezar a tomar usar Ambroxol Stada

No tome Ambroxol Stada:

  • Si es alérgico al ambroxol hidrocloruro o a alguno de los demás componentes de este medicamento (incluidos en la sección 6).
  • En niños menores de 2 años de edad.

Advertencias y precauciones

Consulte a su médico o farmacéutico antes de empezar a tomar Ambroxol Stada.

Si tiene problemas relacionados con el funcionamiento del riñón o del hígado, consulte a su médico antes de utilizar Ambroxol Stada.

Si usted sufre de una enfermedad rara de los bronquios con acumulación aumentada de mocos (p.e. discinesia ciliar primaria). Aquí, el moco no puede ser transportado fuera de los pulmones. En este caso, únicamente tomar Ambroxol Stada bajo la supervisión de un médico.

En indicaciones respiratorias agudas, si se nota un empeoramiento de los síntomas o ausencia de mejora después de 4-5 días de tratamiento, pare el tratamiento con Ambroxol Stada y consulte a su médico inmediatamente.

Se han recibido notificaciones de reacciones cutáneas graves asociadas a la administración de ambroxol hidrocloruro. Si le aparece una erupción en la piel (incluidas lesiones de las mucosas de, por ejemplo, la boca, la garganta, la nariz, los ojos y los genitales), deje de usar Ambroxol Drehm y consulte a su médico inmediatamente.

Niños

Ambroxol Stada no debe ser utilizado en niños menores de 2 años.

Otros medicamentos y Ambroxol Stada

Informe a su médico o farmacéutico si está utilizando, ha utilizado recientemente o pudiera tener que utilizar cualquier otro medicamento.

No se conocen interacciones adversas de Ambroxol Stada con otros medicamentos.

No usar ambroxol con medicamentos para la tos seca.

Embarazo,lactancia y fertilidad

Si está embarazada o en periodo de lactancia, cree que podría estar embarazada o tiene intención de quedarse embarazada, consulte a su médico o farmacéutico antes de utilizar este medicamento.

No se han observado efectos nocivos durante el embarazo. Sin embargo, Ambroxol Stada no debe tomarse durante el primer trimestre de embarazo.

Ambroxol hidrocloruro se excreta en la leche materna, por lo que Ambroxol Stada no se recomienda durante la lactancia.

Conducción y uso de máquinas

No hay estudios sobre los efectos de Ambroxol Stada en la habilidad para conducir y usar máquinas. Sin embargo, no hay evidencias de efectos que pueda tener este medicamento en la habilidad para conducir y usar máquinas.

Ambroxol Stada contiene sorbitol

Este medicamento contiene 245 mg de sorbitol (E420) en cada ml. El sorbitol es una fuente de fructosa. Si su médico le ha indicado que usted (o su hijo) padecen una intolerancia a ciertos azúcares, o se les ha diagnosticado intolerancia hereditaria a la fructosa (IHF), una enfermedad genética rara, en la que el paciente no puede descomponer la fructosa, consulte usted (o su hijo) con su médico antes de tomar este medicamento.

Ambroxol Stada contiene ácido benzoico

Este medicamento contiene 1,75 mg de ácido benzoico en cada ml. El ácido benzoico puede aumentar el riesgo de ictericia (coloración amarillenta de la piel y los ojos) en recién nacidos (hasta de 4 semanas de edad).

Ambroxol Stada contiene propilenglicol

Este medicamento contiene 1,59 mg de propilenglicol en cada ml. Si su bebé tiene menosde 4 semanas de edad, consulte con su médico o farmacéutico, en particular si al bebé se le han administrado otros medicamentos que contengan propilenglicol o alcohol.

3. Cómo tomar Ambroxol Stada

Siga exactamente las instrucciones de administración del medicamento contenidas en este prospecto o las indicadas por su médico o farmacéutico. En caso de duda pregunte a su médico o farmacéutico.

La dosis recomendada es:

Adultos y adolescentes mayores de 12 años

5 ml, 3 veces al día durante 2-3 días

después:

5 ml, 2 veces al día.

Niños de 6 a 12 años

2,5 ml, 2-3 veces al día

Niños de 2 a 5 años

1,25 ml, 3 veces al día

Niños menores de 2 años

Ambroxol Stada no debe ser usado en niños menores de 2 años.

Método de administración

Para facilitar la administración del jarabe, el estuche contiene una cuchara medidora.

Ambroxol Stada puede ser tomado con o sin alimentos.

Duración del uso

El tratamiento no debe exceder los 4-5 días sin consultar a un médico.

Si tomamás Ambroxol Stada del que debe

No se conocen casos de intoxicación con Ambroxol Stada.

De acuerdo con los informes de sobredosis accidental y/o errores en la medicación, los síntomas observados son consistentes con los efectos secundarios de Ambroxol Stada cuando se toma en la dosis recomendada, y un tratamiento sintomático puede ser necesario.

En caso de sobredosis o ingestión accidental, consulte a su médico o farmacéutico, o llame al Servicio de Información Toxicológica, teléfono 915 620 420, indicando el medicamento y la cantidad ingerida.

Si olvidó tomar Ambroxol Stada

No tome una dosis doble para compensar las dosis olvidadas.

Si tiene cualquier otra duda sobre el uso de este medicamento, pregunte a su médico o farmacéutico.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Posibles efectos adversos

Al igual que todos los medicamentos, este medicamento puede producir efectos adversos, aunque no todas las personas los sufran.

Si experimenta cualquier efecto adverso de los siguientes, pare de tomar Ambroxol Stada inmediatamente y consulte con su doctor:

No conocidos (no se puede estimar la frecuencia a partir de los datos disponibles)

  • reacciones anafilácticas que incluyen choque anafiláctico, angioedema (hinchazón de rápida progresión de la piel, de los tejidos subcutáneos, de las mucosas o de tejidos submucosos) y prurito
  • reacciones adversas cutáneas adversas graves (tales como eritema multiforme, síndrome de Stevens-Johnson/necrólisis epidérmica tóxica y pustulosis exantemosa generalizada aguda).

Otros efectos adversos que pueden darse:

Frecuentes (pueden afectar hasta 1 de cada 10 personas):

  • náuseas
  • sensibilidad disminuida de la boca y la garganta (hipoestesia)
  • alteración del sentido del gusto

Poco frecuentes (pueden afectar hasta 1 de cada 100 personas):

  • vómitos, diarrea, dispepsia, dolor abdominal
  • boca seca
  • fiebre
  • reacciones de la membrana mucosa

Raras (pueden afectar hasta 1 de cada 1.000 personas):

  • reacciones de hipersensibilidad
  • exantema, urticaria
  • sequedad de garganta

Comunicación de efectos adversos:

Si experimenta cualquier tipo de efecto adverso, consulte a su médico o farmacéutico, incluso si se trata de posibles efectos adversos que no aparecen en este prospecto. También puede comunicarlos directamente a través del Sistema Español de Farmacovigilancia de Medicamentos de Uso Humano: http://www.notificaram.es. Mediante la comunicación de efectos adversos usted puede contribuir a proporcionar más información sobre la seguridad de este medicamento.

5. Conservación de Ambroxol Stada

Mantener este medicamento fuera de la vista y del alcance de los niños.

No use este medicamento después de la fecha de caducidad que aparece en la etiqueta del envase y en el estuche después de CAD. La fecha de caducidad es el último día del mes que se indica.

Este medicamento no requiere condiciones especiales de conservación.

Caducidad después de la primera apertura: 6 meses.

Los medicamentos no se deben tirar por los desagües ni a la basura. Deposite los envases y los medicamentos que no necesite en el Punto SIGRE de la farmacia. En caso de duda pregunte a su farmacéutico cómo deshacerse de los envases y de los medicamentos que no necesita. De esta forma, ayudará a proteger el medio ambiente.

6. Contenido del envase e información adicional

Composición de Ambroxol Stada

  • El principio activo es ambroxol hidrocloruro. Ambroxol Stada contiene 30 mg de ambroxol hidrocloruro cada 5 ml de jarabe.

Cada ml de Ambroxol Stada contiene 6 mg de ambroxol hidrocloruro.

  • Los demás componentes son: Hidroxietilcelulosa, Sorbitol líquido (no cristalizante) (E420), Glicerol (85 por ciento) (E422), Ácido benzoico (E210), Acesulfamo de potasio, Sabor de fresa (Propilenglicol (E1520), Glicerol, 2-etil-3-hidroxi-4-pirona, Lactato de etilo, Metil cinamato, Ácido butírico, Ácido 2-metilbutírico, Ácido hexanoico, Butanodiona), Sabor a vainilla (Color caramelo (E150d), Propilenglicol (E1520)) y Agua purificada.

Aspecto del producto y contenido del envase

Ambroxol Stada es un jarabe claro, prácticamente incoloro, ligeramente viscoso presentado en un frasco ámbar de vidreo tipo III con un tapón blanco de polietileno inviolable y un sistema de seguridad para niños.

Está disponible en los tamaños: 100 ml, 125 ml, 200 ml o 250 ml de jarabe.

Puede que no todos los tamaños de envase estén comercializados.

Titular de la autorización de comercialización

Laboratorio STADA, S.L.

Frederic Mompou, 5

08960 Sant Just Desvern (Barcelona)

España

Responsable de la fabricación

STADA Arzneimittel AG

Stadastrasse 2 – 18

61118 Bad Vilbel, Alemania

STADA Arzneimittel GmbH

Muthgasse 36/2

1190 Vienna, Austria

Laboratórios Basi - Indústria Farmacêutica, S.A.

Parque Industrial Manuel Lourenço Ferreira, Lotes 8, 15 e 16, Mortágua

3450-232, Portugal

Este medicamento está autorizado en los Estados Miembros del Espacio Económico Europeo con los siguientes nombres:

AT Ambroxol Stada 30 mg/5 ml Sirup

DE Ambroxolhydrochlorid AL 30 mg/5 ml Sirup

ES Ambroxol Stada 6 mg/ml jarabe EFG

Fecha de la última revisión de este prospecto: Marzo 2019

La información detallada de este medicamento está disponible en la página web de la Agencia Española de Medicamentos y Productos Sanitarios (AEMPS) http://www.aemps.gob.es/.

Online doctors for AMBROXOL STADA 6 mg/ml SYRUP

Discuss questions about AMBROXOL STADA 6 mg/ml SYRUP, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

4.4 (93)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

Camera Book a video appointment
€69
5.0 (40)
Doctor

Lina Travkina

Family medicine 13 years exp.

Dr. Lina Travkina is a licensed family and preventive medicine doctor based in Italy. She provides online consultations for adults and children, supporting patients across all stages of care – from acute symptom management to long-term health monitoring and prevention.

Areas of medical care include:

  • Respiratory conditions: colds, flu, acute and chronic bronchitis, mild to moderate pneumonia, bronchial asthma.
  • ENT and eye conditions: sinusitis, tonsillitis, pharyngitis, otitis, infectious and allergic conjunctivitis.
  • Digestive issues: gastritis, acid reflux (GERD), IBS, dyspepsia, bloating, constipation, diarrhoea, functional bowel symptoms, intestinal infections.
  • Urological and infectious diseases: acute and recurrent cystitis, bladder and kidney infections, prevention of recurrent UTIs, asymptomatic bacteriuria.
  • Chronic conditions: hypertension, diabetes, hypercholesterolemia, metabolic syndrome, thyroid disorders, excess weight.
  • Neurological and general symptoms: headache, migraine, dizziness, fatigue, sleep disturbances, reduced concentration, anxiety, asthenia.
  • Chronic pain support: back, neck, joint, and muscle pain, tension syndromes, pain associated with osteochondrosis and chronic conditions.

Additional care areas:

  • Preventive consultations and check-up planning.
  • Medical advice and follow-up consultations.
  • Test interpretation and diagnostic guidance.
  • Structured support for undiagnosed complaints.
  • Second opinion on diagnoses and treatment plans.
  • Nutritional and lifestyle support for vitamin deficiencies, anaemia, metabolic issues.
  • Post-operative recovery support and pain management.
  • Preconception counselling and postpartum support.
  • Immunity support and strategies to reduce frequency of infections.

Dr. Travkina combines evidence-based medicine with an attentive, personalised approach. Her consultations focus not only on treatment, but also on prevention, recovery, and long-term wellbeing.

If during the consultation it becomes clear that your case requires in-person assessment or specialised care outside of her scope, the session will be terminated and the payment fully refunded.

Camera Book a video appointment
€70
0.0 (0)
Doctor

Hocine Lokchiri

General medicine 21 years exp.

Dr. Hocine Lokchiri is a French consultant with over 20 years of experience in General and Emergency Medicine. He works with adults and children, helping patients with urgent symptoms, infections, sudden health changes and everyday medical concerns that require timely evaluation. His background includes clinical practice in France, Switzerland and the United Arab Emirates, which allows him to navigate different healthcare systems and manage a wide range of conditions with confidence. Patients value his calm, structured approach, clear explanations and evidence-based decision-making.

Online consultations with Dr. Lokchiri are suitable for many situations when someone needs quick medical guidance, reassurance or a clear next step. Common reasons for booking include:

  • fever, chills, fatigue and viral symptoms
  • cough, sore throat, nasal congestion, breathing discomfort
  • bronchitis and mild asthma flare-ups
  • nausea, diarrhoea, abdominal pain, digestive infections
  • rashes, allergic reactions, redness, insect bites
  • muscle or joint pain, mild injuries, sprains
  • headache, dizziness, migraine symptoms
  • stress-related symptoms, sleep disturbances
  • questions about test results and treatment plans
  • management of chronic conditions in stable phases
Many patients reach out when symptoms appear suddenly and cause concern, when a child becomes unwell unexpectedly, when a rash changes or spreads, or when it’s unclear whether an in-person examination is necessary. His emergency medicine background is particularly valuable online, helping patients understand risk levels, identify warning signs and choose safe next steps.

Some situations are not suitable for online care. If a patient has loss of consciousness, severe chest pain, uncontrolled bleeding, seizures, major trauma or symptoms suggesting a stroke or heart attack, he will advise seeking immediate local emergency services. This improves safety and ensures patients receive the right level of care.

Dr. Lokchiri’s professional training includes:

  • Advanced Trauma Life Support (ATLS)
  • Basic and Advanced Cardiac Life Support (BLS/ACLS)
  • Pediatric Advanced Life Support (PALS)
  • Prehospital Trauma Life Support (PHTLS)
  • eFAST and critical care transthoracic echocardiography
  • aviation medicine
He is an active member of several professional organisations, including the French Society of Emergency Medicine (SFMU), the French Association for Emergency Physicians (AMUF) and the Swiss Society of Emergency and Rescue Medicine (SGNOR). In consultations, he works with clarity and precision, helping patients understand their symptoms, possible risks and the safest treatment options.
Camera Book a video appointment
€58
5.0 (5)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques. For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance. Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults. In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions. Patients commonly seek his care for: 

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns

Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.

Camera Book a video appointment
€80
5.0 (1055)
Doctor

Andrei Popov

General medicine 7 years exp.

Dr. Andrei Popov is a family physician with specialized training in the management of chronic pain. He provides video consultations for adults in Spain and across Europe: whether you have been living with pain for months that no one has been able to properly explain, or you need to resolve a health issue without waiting weeks for an appointment.

His approach is clear: to listen, organize your case, and provide you with a practical roadmap based on evidence-based medicine and adapted to your medical history and personal needs.

Pain: how he can help

  • Chronic pain (more than 3 months
  • Migraine and recurrent or high-intensity headaches
  •  Neck, lower back, back and joint pain
  •  Post-traumatic pain after injuries or surgeries
  •  Pain of neurological origin: neuralgia, neuropathic pain, fibromyalgia

General medicine

  • Frequent respiratory infections (cold, flu, persistent cough)
  • Hypertension, diabetes and metabolic disorders
  • Review of laboratory tests and MRI/CT reports (explained in clear language)
  • Preventive medicine and health monitoring
  • Second opinions and treatment adjustments (when clinically appropriate)

What the consultation is like
 Each session lasts up to 30 minutes. We review symptoms, medical history, medications and any tests you provide, and you finish the consultation with a clear treatment plan, defined next steps, and criteria to understand when follow-up may be needed. If warning signs are detected, he will clearly advise whether you need in-person care or urgent medical attention.

Camera Book a video appointment
€80

Frequently Asked Questions

Is a prescription required for AMBROXOL STADA 6 mg/ml SYRUP?
AMBROXOL STADA 6 mg/ml SYRUP requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in AMBROXOL STADA 6 mg/ml SYRUP?
The active ingredient in AMBROXOL STADA 6 mg/ml SYRUP is ambroxol. This information helps identify medicines with the same composition but different brand names.
Who manufactures AMBROXOL STADA 6 mg/ml SYRUP?
AMBROXOL STADA 6 mg/ml SYRUP is manufactured by Laboratorio Stada S.L.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of AMBROXOL STADA 6 mg/ml SYRUP online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether AMBROXOL STADA 6 mg/ml SYRUP is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to AMBROXOL STADA 6 mg/ml SYRUP?
Other medicines with the same active substance (ambroxol) include AMBROXOL ALDO-UNION 15 mg/2 ml ORAL SOLUTION OR CONCENTRATE FOR NEBULIZER INHALATION, AMBROXOL CINFA 3 mg/ml SYRUP, AMBROXOL CINFA 6 mg/ml SYRUP. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media